Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Delfi Diagnostics Inc.
Alpha Biopharma (Jiangsu) Co., Ltd.
Hoffmann-La Roche
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Jiangsu HengRui Medicine Co., Ltd.
AVEO Pharmaceuticals, Inc.